National Service Framework for Coronary Heart Disease

March 17, 2018

The new NHS 1 announced the Government’s intention to modernise the NHS. It set out a number of important principles and a range of measures to improve the quality of care and reduce unacceptable variations. Services should be accessible on the basis of need irrespective of age, gender, race, culture, religion, disability, sexual orientation or where people happen to live, and be responsive to individuals’ needs. Modernising Social Services 2 similarly included proposals for ensuring the delivery of high quality personal social services.

Spotlight

RxGenomix

RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage.

OTHER WHITEPAPERS
news image

INDICATION-SPECIFIC PRICING OF PHARMACEUTICALS IN THE UNITED STATES HEALTH CARE SYSTEM

whitePaper | November 24, 2022

The 2015 ICER Policy Summit convened an influential group of evidence policy leaders from insurers, pharmacy benefit management firms.

Read More
news image

Future of medical science

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

Read More
news image

DIGITAL HEALTH

whitePaper | April 28, 2022

The authors would like to express their gratitude to those who contributed to this research either by participating in the surveys carried out during the EIT Health Morning Health Talks or the in-depth interviews.

Read More
news image

Tips for tailoring eConsent for Optimal Patient Centricity.

whitePaper | September 12, 2022

While informed consent is a critical process for ensuring participant autonomy in clinical research, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels.

Read More
news image

Three Challenges Facing Study Start Up and the Low-Code Automation Solution

whitePaper | November 24, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies

Read More
news image

Workforce Well-Being: Digital Innovations For Improving The Life Of A Healthcare Worker

whitePaper | November 14, 2022

The pandemic has had a disproportionately negative impact on female physicians, the study found. In a multivariable analysis that adjusted for personal characteristics such as age and professional characteristics.

Read More

Spotlight

RxGenomix

RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage.

Events